209 related articles for article (PubMed ID: 22991316)
1. Enhanced MRI relaxivity of Gd(3+) -based contrast agents geometrically confined within porous nanoconstructs.
Sethi R; Ananta JS; Karmonik C; Zhong M; Fung SH; Liu X; Li K; Ferrari M; Wilson LJ; Decuzzi P
Contrast Media Mol Imaging; 2012; 7(6):501-8. PubMed ID: 22991316
[TBL] [Abstract][Full Text] [Related]
2. Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T1 contrast.
Ananta JS; Godin B; Sethi R; Moriggi L; Liu X; Serda RE; Krishnamurthy R; Muthupillai R; Bolskar RD; Helm L; Ferrari M; Wilson LJ; Decuzzi P
Nat Nanotechnol; 2010 Nov; 5(11):815-21. PubMed ID: 20972435
[TBL] [Abstract][Full Text] [Related]
3. Geometrical confinement of Gd(DOTA) molecules within mesoporous silicon nanoconstructs for MR imaging of cancer.
Gizzatov A; Stigliano C; Ananta JS; Sethi R; Xu R; Guven A; Ramirez M; Shen H; Sood A; Ferrari M; Wilson LJ; Liu X; Decuzzi P
Cancer Lett; 2014 Sep; 352(1):97-101. PubMed ID: 24931336
[TBL] [Abstract][Full Text] [Related]
4. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
[TBL] [Abstract][Full Text] [Related]
5. Improving Longitudinal Transversal Relaxation Of Gadolinium Chelate Using Silica Coating Magnetite Nanoparticles.
Xu K; Liu H; Zhang J; Tong H; Zhao Z; Zhang W
Int J Nanomedicine; 2019; 14():7879-7889. PubMed ID: 31576129
[TBL] [Abstract][Full Text] [Related]
6. Nano assembly and encapsulation; a versatile platform for slowing the rotation of polyanionic Gd(3+) -based MRI contrast agents.
Farashishiko A; Chacón KN; Blackburn NJ; Woods M
Contrast Media Mol Imaging; 2016; 11(2):154-9. PubMed ID: 26708733
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of relaxivity rates of Gd-DTPA complexes by intercalation into layered double hydroxide nanoparticles.
Xu ZP; Kurniawan ND; Bartlett PF; Lu GQ
Chemistry; 2007; 13(10):2824-30. PubMed ID: 17186555
[TBL] [Abstract][Full Text] [Related]
8. Gadolinium-containing copolymeric chelates--a new potential MR contrast agent.
Unger EC; Shen D; Wu G; Stewart L; Matsunaga TO; Trouard TP
MAGMA; 1999 Aug; 8(3):154-62. PubMed ID: 10504042
[TBL] [Abstract][Full Text] [Related]
9. P22 viral capsids as nanocomposite high-relaxivity MRI contrast agents.
Qazi S; Liepold LO; Abedin MJ; Johnson B; Prevelige P; Frank JA; Douglas T
Mol Pharm; 2013 Jan; 10(1):11-7. PubMed ID: 22656692
[TBL] [Abstract][Full Text] [Related]
10. Anti-EpCAM scFv gadolinium chelate: a novel targeted MRI contrast agent for imaging of colorectal cancer.
Khantasup K; Saiviroonporn P; Jarussophon S; Chantima W; Dharakul T
MAGMA; 2018 Oct; 31(5):633-644. PubMed ID: 29737435
[TBL] [Abstract][Full Text] [Related]
11. Relaxivity enhancement of aquated Tris(β-diketonate)gadolinium(III) chelates by confinement within ultrashort single-walled carbon nanotubes.
Law JJ; Guven A; Wilson LJ
Contrast Media Mol Imaging; 2014; 9(6):409-12. PubMed ID: 24764189
[TBL] [Abstract][Full Text] [Related]
12. GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents.
Laus S; Ruloff R; Tóth E; Merbach AE
Chemistry; 2003 Aug; 9(15):3555-66. PubMed ID: 12898682
[TBL] [Abstract][Full Text] [Related]
13. A benzene-core trinuclear GdIII complex: towards the optimization of relaxivity for MRI contrast agent applications at high magnetic field.
Livramento JB; Helm L; Sour A; O'Neil C; Merbach AE; Tóth E
Dalton Trans; 2008 Mar; (9):1195-202. PubMed ID: 18283380
[TBL] [Abstract][Full Text] [Related]
14. Biocompatible nanotemplate-engineered nanoparticles containing gadolinium: stability and relaxivity of a potential MRI contrast agent.
Zhu D; White RD; Hardy PA; Weerapreeyakul N; Sutthanut K; Jay M
J Nanosci Nanotechnol; 2006 Apr; 6(4):996-1003. PubMed ID: 16736756
[TBL] [Abstract][Full Text] [Related]
15. The effect of a phosphodiester linking group on albumin binding, blood half-life, and relaxivity of intravascular diethylenetriaminepentaacetato aquo gadolinium(III) MRI contrast agents.
McMurry TJ; Parmelee DJ; Sajiki H; Scott DM; Ouellet HS; Walovitch RC; Tyeklár Z; Dumas S; Bernard P; Nadler S; Midelfort K; Greenfield M; Troughton J; Lauffer RB
J Med Chem; 2002 Aug; 45(16):3465-74. PubMed ID: 12139457
[TBL] [Abstract][Full Text] [Related]
16. The use of a binary chelate formulation: Could gadolinium based linear contrast agents be rescued by the addition of zinc selective chelates?
Gibby W; Parish W; Merrill RM; Fernandez D; Anderson CR; Merchel E; Parr R
Magn Reson Imaging; 2019 May; 58():76-81. PubMed ID: 30639754
[TBL] [Abstract][Full Text] [Related]
17. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
Caravan P
Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
[TBL] [Abstract][Full Text] [Related]
18. Selective anchoring of Gd(III) chelates on the external surface of organo-modified mesoporous silica nanoparticles: a new chemical strategy to enhance relaxivity.
Carniato F; Tei L; Arrais A; Marchese L; Botta M
Chemistry; 2013 Jan; 19(4):1421-8. PubMed ID: 23233428
[TBL] [Abstract][Full Text] [Related]
19. Gold nanoparticles functionalised with fast water exchanging Gd3+ chelates: linker effects on the relaxivity.
Ferreira MF; Gonçalves J; Mousavi B; Prata MI; Rodrigues SP; Calle D; López-Larrubia P; Cerdan S; Rodrigues TB; Ferreira PM; Helm L; Martins JA; Geraldes CF
Dalton Trans; 2015 Mar; 44(9):4016-31. PubMed ID: 25611006
[TBL] [Abstract][Full Text] [Related]
20. Gd(III) complexes intercalated into hydroxy double salts as potential MRI contrast agents.
Jin M; Spillane DE; Geraldes CF; Williams GR; Bligh SW
Dalton Trans; 2015 Dec; 44(47):20728-34. PubMed ID: 26568157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
